januvia and glp 1 These highlights do not include all the information needed to use safely effectively. See full prescribing information for JANUVIA. JANUVIA® (sitagliptin) tablets, for oral useInitial U.S. Approval: 2006 New studies back safety of

Energy levels: Some people experience a noticeable increase in energy on tirzepatide, potentially related to improved glucose metabolism and the effects of GIP receptor activation

After menopause, estrogen levels drop sharply, leading to: Increased osteoclast activity Accelerated bone resorption Rising urinary DPD levels This makes DPD testing particularly valuable for postmenopausal women , helping identify those at highest risk for rapid bone loss

Public Health 19 , 8919 (2022)

Malignant transformation in a nontumorigenic human prostatic epithelial cell line

Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis

This content was created with AI-assisted drafting support and reviewed and edited by the HormoneSynergy team for accuracy, clarity and alignment with its clinical perspective